Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-16

Clinical Trial Update: OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing oxycodone/naloxone prolonged-release (OXN PR) with oxycodone prolonged-release (OXY PR) for postoperative pain after knee arthroplasty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXN PR (Oxycodone/naloxone prolonged-release)
  • OXY PR (Oxycodone prolonged-release)

Snippet

Sponsor: Mundipharma Oy | Conditions: Post Operative Pain | Phase 4 | Status: COMPLETED | Results posted: 2012-02-16